www.foxbusiness.com
A new study by Jefferies analyst Sheila Kahyaoglu suggests U.S. airlines could save $580 million annually due to passengers losing weight from popular drugs like Ozempic and Wegovy. Fuel cost reductions would drive these savings for carriers like American, Delta, Southwest, and United. The report highlights that airlines historically cut costs by reducing aircraft weight. Meanwhile, drug maker Novo Nordisk has launched the first oral version of its GLP-1 medication, expanding access for patients who prefer a pill over an injection. (98 words)
Read More
